Obesity Increases the Risk for High-grade Prostate Cancer: Results from the REDUCE study

Por Vidal, Adriana C., Howard, Lauren E., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Publicado no Cancer Epidemiol Biomarkers Prev (2014)

Aspirin, NSAID and risk of prostate cancer: Results from the REDUCE study

Por Vidal, Adriana C., Howard, Lauren E., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Publicado no Clin Cancer Res (2014)

The Association Between Phosphodiesterase Type-5 Inhibitors and Prostate Cancer: Results from the REDUCE Study

Por Jamnagerwalla, Juzar, Howard, Lauren E., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Publicado no J Urol (2016)

Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study

Por Sourbeer, Katharine N., Howard, Lauren E., Andriole, Gerald L., Moreira, Daniel M., Castro-Santamaria, Ramiro, Freedland, Stephen J., Vidal, Adriana C.
Publicado no BJU Int (2014)

Statin use, serum lipids and prostate inflammation in men with a negative prostate biopsy: results from the REDUCE trial

Por Allott, Emma H., Howard, Lauren E., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Publicado no Cancer Prev Res (Phila) (2017)

Baseline Subject Characteristics Predictive of Compliance with Study-Mandated Prostate Biopsy in Men at Risk of Prostate Cancer: Results from REDUCE

Por Fischer, Sean, Sun, Stephanie, Howard, Lauren E., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Vidal, Adriana C., Freedland, Stephen J.
Publicado no Prostate Cancer Prostatic Dis (2016)

Smoking and risk of low- and high-grade prostate cancer: Results from the REDUCE study

Por Ho, Tammy, Howard, Lauren E., Vidal, Adriana C., Gerber, Leah, Moreira, Daniel, McKeever, Madeleine, Andriole, Gerald, Castro-Santamaria, Ramiro, Freedland, Stephen J.
Publicado em 2014

Metformin Use and Risk of Prostate Cancer: Results from the REDUCE Study

Por Feng, Tom, Sun, Xizi, Howard, Lauren E., Vidal, Adriana C., Gaines, Alexis R., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freedland, Stephen J.
Publicado no Cancer Prev Res (Phila) (2015)

Serum cholesterol and risk of high-grade prostate cancer: results from the REDUCE study

Por Jamnagerwalla, Juzar, Howard, Lauren E., Allott, Emma H., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Freeman, Michael R., Freedland, Stephen J.
Publicado no Prostate Cancer Prostatic Dis (2017)

Geographic differences in baseline prostate inflammation and relationship with subsequent prostate cancer risk: results from the multinational REDUCE trial

Por Allott, Emma H., Markt, Sarah C., Howard, Lauren E., Vidal, Adriana C., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Mucci, Lorelei A., Freedland, Stephen J.
Publicado no Cancer Epidemiol Biomarkers Prev (2018)

Racial differences in prostate inflammation: results from the REDUCE study

Por Vidal, Adriana C., Chen, Zinan, Howard, Lauren E., Moreira, Daniel M., Castro-Santamaria, Ramiro, Andriole, Gerald L., Taioli, Emanuela, Fowke, Jay H., Knudsen, Beatrice, Drake, Charles G., Nickel, J. Curtis, Freedland, Stephen J.
Publicado no Oncotarget (2016)